home / stock / avdl / avdl news


AVDL News and Press, Avadel Pharmaceuticals plc From 05/19/22

Stock Information

Company Name: Avadel Pharmaceuticals plc
Stock Symbol: AVDL
Market: NASDAQ
Website: avadel.com

Menu

AVDL AVDL Quote AVDL Short AVDL News AVDL Articles AVDL Message Board
Get AVDL Alerts

News, Short Squeeze, Breakout and More Instantly...

AVDL - Avadel to Present Clinical Data for FT218 at SLEEP 2022

DUBLIN, Ireland, May 19, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, today announced the presentation of clinical data for FT218 in nine posters at the 36 th Annual Meeting of the A...

AVDL - Avadel Pharmaceuticals to Present at the H.C. Wainwright Global Investment Conference

DUBLIN, Ireland, May 18, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that Greg Divis, Chief Executive Officer of Avadel, will participate in a fireside chat at the H.C. ...

AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Gregory Divis on Q1 2022 Results - Earnings Call Transcript

Avadel Pharmaceuticals plc (AVDL) Q1 2022 Earnings Conference Call May 9, 2022 08:30 ET Company Participants Brandi Robinson - Senior Vice President of Corporate Affairs Douglas Williamson - Chief Medical Officer Gregory Divis - Chief Executive Officer Jennifer Gudeman - Vice President of Med...

AVDL - Avadel Pharmaceuticals GAAP EPS of -$0.45 misses by $0.02

Avadel Pharmaceuticals press release (NASDAQ:AVDL): Q1 GAAP EPS of -$0.45 misses by $0.02. Cash, cash equivalents and marketable securities were $123.5 million as of March 31, 2022. For further details see: Avadel Pharmaceuticals GAAP EPS of -$0.45 misses by $0.02

AVDL - Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2022 Financial Results

FDA review of NDA for FT218 continues; launch readiness preparations on-track to support potential commercial launch Presented interim results from ongoing RESTORE open-label extension / switch study of FT218 highlighting overwhelming patient preference for the once-at-bedti...

AVDL - Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9

DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Monday, May 9, 2022, to prov...

AVDL - FFIE, EVOK and ZY among mid-day movers

Gainers: Evoke Pharma (EVOK) +151%. Avadel Pharmaceuticals (AVDL) +26%. Arch Resources (ARCH) +21%. Magnachip Semiconductor (MX) +20%. TradeUP Global (TUGCU) +20%. Jiuzi Holdings (JZXN) +19%. Forge Global Holdings (FRGE) +18%. Morphic Holding (MORF) +16%. Flexsteel Industries (FLXS) +15%. Sky...

AVDL - Why Avadel Pharmaceuticals Stock Is Skyrocketing Today

Shares of Avadel Pharmaceuticals (NASDAQ: AVDL) had skyrocketed 33.5% higher at 11:09 a.m. ET on Tuesday. The big jump came after the company issued a statement earlier today about its stock's volatility on Monday, which had led to a temporary trading halt. Avadel CEO Greg Divis...

AVDL - Avadel, AgeX top healthcare gainers; Protagonist, Nkarta lead losers' pack

Gainers: Avadel Pharmaceuticals (AVDL) +30%. AgeX Therapeutics (AGE) +9%. Helius Medical Technologies (HSDT) +7%. Quipt Home Medical (QIPT) +7%. Gamida Cell (GMDA) +5%. Losers: Protagonist Therapeutics (PTGX) -47%. Nkarta (NKTX) -14%. ...

AVDL - Hot Penny Stocks to Buy Today? 3 For Your Watchlist 

What To Know About Buying Penny Stocks on April 26th With so many penny stocks to choose from, it can seem difficult to pick the best ones to buy. However, because there is such a large variety of small caps out there, finding ones that have the opportunity to be profitable, is complete...

Previous 10 Next 10